PGLYRP2
Basic information
Region (hg38): 19:15468645-15498956
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PGLYRP2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 21 | 24 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 21 | 2 | 1 |
Variants in PGLYRP2
This is a list of pathogenic ClinVar variants found in the PGLYRP2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-15468716-T-C | not specified | Uncertain significance (Aug 23, 2021) | ||
19-15468726-A-C | not specified | Likely benign (Aug 16, 2021) | ||
19-15469700-G-T | not specified | Uncertain significance (Dec 14, 2023) | ||
19-15469781-T-C | not specified | Uncertain significance (Oct 04, 2022) | ||
19-15469826-C-T | not specified | Uncertain significance (Nov 01, 2022) | ||
19-15469873-C-T | not specified | Uncertain significance (Aug 22, 2022) | ||
19-15471938-A-C | not specified | Uncertain significance (Nov 30, 2022) | ||
19-15471996-A-G | not specified | Uncertain significance (May 24, 2024) | ||
19-15472034-A-G | not specified | Uncertain significance (Jan 18, 2022) | ||
19-15475615-T-C | not specified | Uncertain significance (Oct 24, 2023) | ||
19-15475645-A-C | not specified | Uncertain significance (Jul 25, 2023) | ||
19-15475714-C-T | not specified | Uncertain significance (Jan 09, 2024) | ||
19-15475793-G-A | not specified | Uncertain significance (Apr 13, 2022) | ||
19-15475903-C-T | not specified | Uncertain significance (Jun 16, 2024) | ||
19-15475969-C-A | Benign (Mar 29, 2018) | |||
19-15475972-C-G | not specified | Uncertain significance (Oct 27, 2021) | ||
19-15475996-C-T | not specified | Uncertain significance (Apr 12, 2022) | ||
19-15476075-C-T | not specified | Uncertain significance (May 26, 2022) | ||
19-15476177-C-T | not specified | Uncertain significance (May 23, 2023) | ||
19-15476231-C-A | not specified | Uncertain significance (Dec 20, 2023) | ||
19-15476240-T-C | not specified | Uncertain significance (Nov 06, 2023) | ||
19-15476266-C-T | not specified | Likely benign (Feb 16, 2023) | ||
19-15476267-G-T | not specified | Uncertain significance (May 13, 2024) | ||
19-15476345-C-A | not specified | Uncertain significance (Jun 12, 2023) | ||
19-15476345-C-G | not specified | Uncertain significance (Feb 15, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PGLYRP2 | protein_coding | protein_coding | ENST00000340880 | 5 | 30312 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.68e-11 | 0.146 | 125682 | 1 | 65 | 125748 | 0.000262 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.07 | 276 | 331 | 0.835 | 0.0000187 | 3614 |
Missense in Polyphen | 74 | 104.6 | 0.70749 | 1164 | ||
Synonymous | 1.90 | 115 | 144 | 0.798 | 0.00000818 | 1305 |
Loss of Function | 0.603 | 18 | 21.0 | 0.858 | 0.00000126 | 198 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000666 | 0.000666 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.000218 | 0.000217 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000185 | 0.000185 |
Middle Eastern | 0.000218 | 0.000217 |
South Asian | 0.000789 | 0.000752 |
Other | 0.000327 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: May play a scavenger role by digesting biologically active peptidoglycan (PGN) into biologically inactive fragments. Has no direct bacteriolytic activity. {ECO:0000269|PubMed:14506276}.;
- Pathway
- Antimicrobial peptides;Innate Immune System;Immune System
(Consensus)
Recessive Scores
- pRec
- 0.146
Intolerance Scores
- loftool
- 0.841
- rvis_EVS
- 1.47
- rvis_percentile_EVS
- 95.25
Haploinsufficiency Scores
- pHI
- 0.105
- hipred
- N
- hipred_score
- 0.188
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.128
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pglyrp2
- Phenotype
- homeostasis/metabolism phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype; digestive/alimentary phenotype; immune system phenotype; skeleton phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- peptide amidation;pattern recognition receptor signaling pathway;peptidoglycan catabolic process;detection of bacterium;antimicrobial humoral response;negative regulation of interferon-gamma production;negative regulation of natural killer cell differentiation involved in immune response;growth of symbiont in host;innate immune response;regulation of inflammatory response;defense response to Gram-positive bacterium
- Cellular component
- extracellular region;extracellular space;membrane;extracellular exosome
- Molecular function
- zinc ion binding;N-acetylmuramoyl-L-alanine amidase activity;peptidoglycan receptor activity;peptidoglycan binding